A randomized, double-blind, placebo-controlled study of the efficacy and safety of 2 doses of vortioxetine in adults with major depressive disorder.
about
Profile of vortioxetine in the treatment of major depressive disorder: an overview of the primary and secondary literatureThe safety and tolerability of vortioxetine: Analysis of data from randomized placebo-controlled trials and open-label extension studies.Under the Influence: The Interplay among Industry, Publishing, and Drug Regulation.Vortioxetine: a New Treatment for Major Depressive Disorder.Safety and tolerability of vortioxetine (15 and 20 mg) in patients with major depressive disorder: results of an open-label, flexible-dose, 52-week extension study.Has the rising placebo response impacted antidepressant clinical trial outcome? Data from the US Food and Drug Administration 1987-2013.The efficacy and safety of 10 mg vortioxetine in the treatment of major depressive disorder: a meta-analysis of randomized controlled trialsThe effect of vortioxetine on overall patient functioning in patients with major depressive disorder.A randomized, double-blind, placebo-controlled 8-week trial of the efficacy, safety, and tolerability of 5, 10, and 20 mg/day vortioxetine in adults with major depressive disorder.Antidepressants and, suicide and self-injury: Causal or casual association?Vortioxetine for depression in adults.Vortioxetine versus Duloxetine in the Treatment of Patients with Major Depressive Disorder: A Meta-Analysis of Randomized Controlled Trials.The Effects of Newer Antidepressants on Occupational Impairment in Major Depressive Disorder: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.Relative short-term efficacy and acceptability of agomelatine versus vortioxetine in adult patients suffering from major depressive disorder.Efficacy and safety of vortioxetine for the treatment of major depressive disorder: a randomised double-blind placebo-controlled study.Efficacy of antidepressants: bias in randomized clinical trials and related issues.Italian neurologists' perception on cognitive symptoms in major depressive disorder.Effective Vortioxetine Dose Varies with Extent of Antidepressant Use Across Countries.Vortioxetine overdose in a suicidal attempt: A case report.
P2860
Q26796436-73509FBF-4DA9-4E28-A88F-C3903A2554FAQ31044175-2505ED58-5F65-47D5-A74C-EF1A395D78D2Q34046215-7C5F36EA-220F-42BB-BFC2-AF390FE0B4F4Q34505568-72625B6D-7B82-40A1-9E76-5FA386BE7345Q35918863-9E0A7F41-5E51-45D5-83FE-AFF3F247F38BQ36370168-D43763F1-A374-4B8B-85C3-76DB0C4AAF46Q36653073-B2BC3CA5-3590-4BF2-8CA7-EF16152154C4Q37694366-3BFBE296-FD9E-42E4-AFC3-B22DF2FFEF89Q38371388-0BE15E2E-D0EF-42D4-9237-A3CFD4E15FD0Q38691860-BBA0B491-AA77-42CC-A319-AEF32811D225Q38693309-2BD3CD7E-0807-4B0A-A944-22920D09F0ECQ38805096-89E00E80-F750-4E98-8517-B39B97C30C38Q38817431-085E52FA-990B-4853-A3B5-A60161C9620FQ47657288-1F46E21B-45E6-4490-8EA6-21F0167002CBQ47716057-8D052061-5356-492E-865D-E2F0558F8598Q47772123-E70B9F3E-5E95-4E6F-9E6A-D7D5CFC75362Q48056101-3BBCD5F7-4B11-4CF6-A62F-A48D96C4EA1EQ49384717-63FB8B04-3502-4CAA-BF5C-A95C783B6CC4Q55421482-CE389F70-4ADE-400D-9BEB-EDBC063DB483
P2860
A randomized, double-blind, placebo-controlled study of the efficacy and safety of 2 doses of vortioxetine in adults with major depressive disorder.
description
2015 nî lūn-bûn
@nan
2015 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
A randomized, double-blind, pl ...... ith major depressive disorder.
@ast
A randomized, double-blind, pl ...... ith major depressive disorder.
@en
type
label
A randomized, double-blind, pl ...... ith major depressive disorder.
@ast
A randomized, double-blind, pl ...... ith major depressive disorder.
@en
prefLabel
A randomized, double-blind, pl ...... ith major depressive disorder.
@ast
A randomized, double-blind, pl ...... ith major depressive disorder.
@en
P2093
P356
P1476
A randomized, double-blind, pl ...... ith major depressive disorder.
@en
P2093
Atul R Mahableshwarkar
Madhukar H Trivedi
Michael Serenko
Paula L Jacobsen
Yinzhong Chen
P304
P356
10.4088/JCP.14M09337
P577
2015-05-01T00:00:00Z